Related references
Note: Only part of the references are listed.The differential plasma proteome of obese and overweight individuals undergoing a nutritional weight loss and maintenance intervention
Sergio Oller Moreno et al.
PROTEOMICS CLINICAL APPLICATIONS (2018)
Expansion of the Gene Ontology knowledgebase and resources
S. Carbon et al.
NUCLEIC ACIDS RESEARCH (2017)
UniProt: the universal protein knowledgebase
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2017)
KEGG: new perspectives on genomes, pathways, diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2017)
The Role of ADAM10 in Alzheimer's Disease
Xiang-Zhen Yuan et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathology
D. Tautvydaite et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Revisiting biomarker discovery by plasma proteomics
Philipp E. Geyer et al.
MOLECULAR SYSTEMS BIOLOGY (2017)
CSF biomarkers for Alzheimer disease - approaching consensus
Douglas R. Galasko et al.
NATURE REVIEWS NEUROLOGY (2017)
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology
Sarah Westwood et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease
Douglas C. Dean et al.
JAMA NEUROLOGY (2017)
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood
Kaj Blennow
NEUROLOGY AND THERAPY (2017)
Markers of neuroinflammation associated with Alzheimer′s disease pathology in older adults
Julius Popp et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Proteomic Biomarker Discovery in 1000 Human Plasma Samples with Mass Spectrometry
Omella Cominetti et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer's disease spectrum
Ashley Swanson et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
High-order oligomers of intrinsically disordered brain proteins BASP1 and GAP-43 preserve the structural disorder
Oksana S. Forsova et al.
FEBS JOURNAL (2016)
Proteomics reveals the effects of sustained weight loss on the human plasma proteome
Philipp E. Geyer et al.
MOLECULAR SYSTEMS BIOLOGY (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
Julia Remnestal et al.
PROTEOMICS CLINICAL APPLICATIONS (2016)
Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas
Ilijana Begcevic et al.
CLINICAL PROTEOMICS (2016)
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
Ann De Vos et al.
ALZHEIMERS & DEMENTIA (2015)
Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery
Antonio Nunez Galindo et al.
ANALYTICAL CHEMISTRY (2015)
A comprehensive map and functional annotation of the normal human cerebrospinal fluid proteome
Yang Zhang et al.
JOURNAL OF PROTEOMICS (2015)
Quantitative variability of 342 plasma proteins in a human twin population
Yansheng Liu et al.
MOLECULAR SYSTEMS BIOLOGY (2015)
Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology
Alison L. Baird et al.
FRONTIERS IN NEUROLOGY (2015)
Plasma Proteome Biomarkers of Inflammation in School Aged Children in Nepal
Sun Eun Lee et al.
PLOS ONE (2015)
Molecular diagnostics of neurodegenerative disorders
Megha Agrawal et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2015)
The cerebrospinal fluid Alzheimer profile: Easily said, but what does it mean?
Flora H. Duits et al.
ALZHEIMERS & DEMENTIA (2014)
Quantification of the Brain Proteome in Alzheimer's Disease Using Multiplexed Mass Spectrometry
Sravani Musunuri et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma
Loic Dayon et al.
JOURNAL OF PROTEOME RESEARCH (2014)
In-depth Characterization of the Cerebrospinal Fluid (CSF) Proteome Displayed Through the CSF Proteome Resource (CSF-PR)
Astrid Guldbrandsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
The Plasma Proteome Identifies Expected and Novel Proteins Correlated with Micronutrient Status in Undernourished Nepalese Children
Robert N. Cole et al.
JOURNAL OF NUTRITION (2013)
The Biology/Disease-driven Human Proteome Project (B/D-HPP): Enabling Protein Research for the Life Sciences Community
Ruedi Aebersold et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
Christoph Stumm et al.
NEUROBIOLOGY OF AGING (2013)
Identification of genetic variants influencing the human plasma proteome
Asa Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Dietary patterns and ethnicity are associated with distinct plasma proteomic groups
Bibiana Garcia-Bailo et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Regression shrinkage and selection via the lasso: a retrospective
Robert Tibshirani
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2011)
The endocannabinoid system as a target for the treatment of neurodegenerative disease
Emma L. Scotter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Reduced Reelin Expression Accelerates Amyloid-β Plaque Formation and Tau Pathology in Transgenic Alzheimer's Disease Mice
Samira Kocherhans et al.
JOURNAL OF NEUROSCIENCE (2010)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Establishing the Proteome of Normal Human Cerebrospinal Fluid
Steven E. Schutzer et al.
PLOS ONE (2010)
Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate α-secretase activity
Minji Kim et al.
HUMAN MOLECULAR GENETICS (2009)
Brain-specific Proteins Decline in the Cerebrospinal Fluid of Humans with Huntington Disease
Qiaojun Fang et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Biomarker discovery in neurodegenerative diseases: A proteomic approach
Min Shi et al.
NEUROBIOLOGY OF DISEASE (2009)
Diagnostic lumbar puncture performed in the outpatient setting of a memory clinic. Frequency and risk factors of post-lumbar puncture headache
J. Popp et al.
NERVENARZT (2007)
Morphological and morphometric alterations of Cajal-Retzius cells in early cases of Alzheimer's disease: A Golgi and electron microscope study
SJ Baloyannis
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2005)
Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation
T Saito et al.
NATURE MEDICINE (2005)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
The proprotein convertase PC2 is involved in the maturation of prosomatostatin to somatostatin-14 but not in the somatostatin deficit in Alzheimer's disease
R Winsky-Sommerer et al.
NEUROSCIENCE (2003)
Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia
CL Nilsson et al.
PEPTIDES (2001)
The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site
J Wang et al.
DIABETES (2001)